JP2022554389A5 - - Google Patents

Info

Publication number
JP2022554389A5
JP2022554389A5 JP2022526326A JP2022526326A JP2022554389A5 JP 2022554389 A5 JP2022554389 A5 JP 2022554389A5 JP 2022526326 A JP2022526326 A JP 2022526326A JP 2022526326 A JP2022526326 A JP 2022526326A JP 2022554389 A5 JP2022554389 A5 JP 2022554389A5
Authority
JP
Japan
Prior art keywords
substituted
compound according
groups
composition according
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022526326A
Other languages
English (en)
Japanese (ja)
Other versions
JP7712922B2 (ja
JP2022554389A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/059201 external-priority patent/WO2021092240A1/en
Publication of JP2022554389A publication Critical patent/JP2022554389A/ja
Publication of JP2022554389A5 publication Critical patent/JP2022554389A5/ja
Priority to JP2025117223A priority Critical patent/JP2025148482A/ja
Application granted granted Critical
Publication of JP7712922B2 publication Critical patent/JP7712922B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022526326A 2019-11-05 2020-11-05 炎症性障害を治療するためのMrgprX2アンタゴニスト Active JP7712922B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025117223A JP2025148482A (ja) 2019-11-05 2025-07-11 炎症性障害を治療するためのMrgprX2アンタゴニスト

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962931183P 2019-11-05 2019-11-05
US62/931,183 2019-11-05
US201962931698P 2019-11-06 2019-11-06
US62/931,698 2019-11-06
US202063046461P 2020-06-30 2020-06-30
US63/046,461 2020-06-30
PCT/US2020/059201 WO2021092240A1 (en) 2019-11-05 2020-11-05 Mrgprx2 antagonists for the treatment of inflammatory disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025117223A Division JP2025148482A (ja) 2019-11-05 2025-07-11 炎症性障害を治療するためのMrgprX2アンタゴニスト

Publications (3)

Publication Number Publication Date
JP2022554389A JP2022554389A (ja) 2022-12-28
JP2022554389A5 true JP2022554389A5 (cg-RX-API-DMAC7.html) 2024-05-21
JP7712922B2 JP7712922B2 (ja) 2025-07-24

Family

ID=73646519

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022526326A Active JP7712922B2 (ja) 2019-11-05 2020-11-05 炎症性障害を治療するためのMrgprX2アンタゴニスト
JP2025117223A Pending JP2025148482A (ja) 2019-11-05 2025-07-11 炎症性障害を治療するためのMrgprX2アンタゴニスト

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025117223A Pending JP2025148482A (ja) 2019-11-05 2025-07-11 炎症性障害を治療するためのMrgprX2アンタゴニスト

Country Status (8)

Country Link
US (3) US20230029266A1 (cg-RX-API-DMAC7.html)
EP (1) EP4054554A1 (cg-RX-API-DMAC7.html)
JP (2) JP7712922B2 (cg-RX-API-DMAC7.html)
CN (1) CN114845709B (cg-RX-API-DMAC7.html)
AU (1) AU2020380395A1 (cg-RX-API-DMAC7.html)
CA (1) CA3159766A1 (cg-RX-API-DMAC7.html)
IL (1) IL292690A (cg-RX-API-DMAC7.html)
WO (1) WO2021092240A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3529245A4 (en) 2016-10-24 2020-12-23 Yumanity Therapeutics, Inc. COMPOUNDS AND USES OF THE LATEST
MA47212A (fr) 2017-01-06 2019-11-13 Yumanity Therapeutics Inc Méthodes de traitement de troubles neurologiques
WO2019084157A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. COMPOUNDS AND USES THEREOF
ES3043183T3 (en) 2018-03-23 2025-11-25 Janssen Pharmaceutica Nv Compounds and uses thereof
MA54829A (fr) 2019-01-24 2021-12-01 Yumanity Therapeutics Inc Composés et leurs utilisations
US20230029266A1 (en) 2019-11-05 2023-01-26 Dermira, Inc. MrgprX2 Antagonists for the Treatment of Inflammatory Disorders
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение
TW202334117A (zh) 2020-08-24 2023-09-01 美商達薩瑪治療公司 Sarm1之抑制劑
TW202329937A (zh) 2021-12-03 2023-08-01 美商英塞特公司 雙環胺ck12抑制劑
US12084453B2 (en) 2021-12-10 2024-09-10 Incyte Corporation Bicyclic amines as CDK12 inhibitors
EP4448492B1 (en) 2021-12-17 2026-03-04 Reglagene, Inc. Compositions and methods of making and using small molecules in the treatment of cancer
JP7894535B2 (ja) * 2023-02-28 2026-07-23 レグラジーン、インコーポレイテッド 健康状態の治療のための小分子を作製および使用するための組成物および方法
WO2025002360A1 (zh) * 2023-06-30 2025-01-02 北京普祺医药科技股份有限公司 一种mrgprx2拮抗剂、药物组合物以及其用途
US20250084063A1 (en) 2023-08-18 2025-03-13 Incyte Corporation Bicyclic heterocycles as mrgprx2 antagonists
CN122206668A (zh) * 2023-09-28 2026-06-12 上海翱路生物医药科技有限公司 化合物、组合物及其方法
WO2025130765A1 (en) * 2023-12-18 2025-06-26 Hepaitech (Beijing) Biopharma Technology Co., Ltd. Compounds, compositions and methods thereof
WO2025160430A1 (en) 2024-01-25 2025-07-31 Incyte Corporation Bicyclic heterocycles as mrgprx2 antagonists
WO2025163462A1 (ko) * 2024-02-02 2025-08-07 삼진제약주식회사 헤테로고리를 갖는 mrgprx2((mas-related g-protein coupled receptor member x2) 길항제 유도체와 이의 용도
WO2025222040A1 (en) 2024-04-19 2025-10-23 Escient Pharmaceuticals, Inc. Mrgprx2 modulators for use in treating mrgprx2 dependent conditions in subjects with low ige
WO2026009854A1 (ja) * 2024-07-01 2026-01-08 日本たばこ産業株式会社 ピリダジノン化合物及びその医薬用途
US12630562B2 (en) 2024-08-07 2026-05-19 Arcus Biosciences, Inc. Piperidylurea compounds and methods of use thereof
WO2026112144A1 (en) * 2024-11-20 2026-05-28 Dewpoint Therapeutics, Inc. Modulators of beta catenin and uses thereof

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493555A (en) 1966-03-23 1970-02-03 Nepera Chem Co Inc 3-phenylazo-2,6-pyridyl dicyclopropane-carboxamide
US4152442A (en) 1975-06-05 1979-05-01 Lilly Industries Limited Certain acylamino-oxa (or thia) diazoles in treatment of hypersensitivity conditions
US4328245A (en) 1981-02-13 1982-05-04 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4410545A (en) 1981-02-13 1983-10-18 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4409239A (en) 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
JPH0717589B2 (ja) 1990-01-22 1995-03-01 ファイザー製薬株式会社 新規1,3―ジカルボニル化合物およびその組成物
CH681383A5 (cg-RX-API-DMAC7.html) 1990-04-11 1993-03-15 Alusuisse Lonza Services Ag
JPH05201981A (ja) 1991-08-06 1993-08-10 Ichikawa Gosei Kagaku Kk 2−アミノ−3−ニトロ−5−ハロゲノピリジン類の製造方法
US5290943A (en) 1991-02-21 1994-03-01 Ichikawa Gosei Chemical Co., Ltd. Method of producing 2-acyl amino 5-halogenopyridine compounds
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
US6350458B1 (en) 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
JP2006508042A (ja) 2002-07-18 2006-03-09 ブリストル−マイヤーズ スクイブ カンパニー グルココルチコイド受容体の修飾物質および方法
WO2004069160A2 (en) 2003-01-28 2004-08-19 Smithkline Beecham Corporation Chemical compounds
WO2004089415A2 (en) 2003-04-11 2004-10-21 Novo Nordisk A/S COMBINATIONS OF AN 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND A GLUCOCORTICOID RECEPTOR AGONIST
US7973169B2 (en) 2003-09-06 2011-07-05 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
BRPI0417687A (pt) 2003-12-19 2007-04-03 Pfizer derivados de benzenossulfonilamino-piridin-2-ila e compostos relacionados como inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1 (11-beta-hsd-1) para o tratamento de diabetes e obesidade
BRPI0507278A (pt) * 2004-01-30 2007-06-26 Vertex Pharma moduladores dos transportadores do cassete de ligação ao atp
CA2576971A1 (en) * 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
CN1736989A (zh) 2004-08-20 2006-02-22 中国科学院大连化学物理研究所 一种杂环菊酯类化合物及其在除草杀菌方面的应用
US20060217370A1 (en) * 2005-02-18 2006-09-28 Ethan Burstein Compounds useful for the treatment and prevention of pain and screening methods therefor
BRPI0619052A2 (pt) 2005-11-28 2011-09-20 Hoffmann La Roche compostos, processo para a sua preparação, composições farmacêuticas que os compreendem, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por inibidores de diacilglicerol aciltransferase, e seu uso
WO2007086584A1 (ja) * 2006-01-30 2007-08-02 Meiji Seika Kaisha, Ltd. 新規FabKおよびFabI/K阻害剤
AU2007230911A1 (en) 2006-03-23 2007-10-04 Synta Pharmaceuticals Corp. Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
EP2035005A4 (en) * 2006-06-09 2011-07-06 Kemia Inc THERAPY BASED ON CYTOKINE INHIBITORS
US20080249081A1 (en) * 2006-10-24 2008-10-09 Roger Olsson Compounds for the treatment of pain and screening methods therefor
WO2008050600A1 (en) * 2006-10-25 2008-05-02 Neugen Pharma Inc. Therapeutic or preventive agent for intractable disease based on oxidative stress-mediated cell death as molecular background
WO2008063625A2 (en) 2006-11-20 2008-05-29 Adolor Corporation Pyridine compounds and methods of their use
EP2125799A1 (en) * 2007-02-28 2009-12-02 Smithkline Beecham Corporation Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase
AU2008345225A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
EP2725022B1 (de) 2008-06-13 2017-03-29 Bayer CropScience AG Neue Amide als Schädlingsbekämpfungsmittel
WO2011074658A1 (ja) 2009-12-18 2011-06-23 田辺三菱製薬株式会社 新規抗血小板薬
US20110190269A1 (en) 2010-02-01 2011-08-04 Karlheinz Baumann Gamma secretase modulators
EA201201274A1 (ru) 2010-03-10 2013-04-30 Инджениум Фармасьютиклз Гмбх Ингибиторы протеинкиназ
DE102010012594A1 (de) * 2010-03-23 2011-09-29 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an einem oder mehreren Thiazolderivaten
KR101688978B1 (ko) * 2010-08-18 2016-12-26 중앙대학교 산학협력단 신규한 2-아미노 티아졸 유도체 및 이를 포함하는 항암용 조성물
RU2601550C2 (ru) 2010-12-09 2016-11-10 Вокхардт Лимитед Кетолидные соединения
DE102011083271A1 (de) * 2011-09-23 2013-03-28 Beiersdorf Ag Aromatische Amidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Aromatischen Amidothiazolen
JP6130383B2 (ja) 2011-09-30 2017-05-17 エンドゥ ファーマシューティカルズ,インコーポレイティド ピリジン誘導体
FR2982261B1 (fr) 2011-11-04 2014-06-13 Galderma Res & Dev Nouveaux amides, et leur utilisation pharmaceutique ou cosmetique
WO2014040243A1 (zh) * 2012-09-12 2014-03-20 湖南有色凯铂生物药业有限公司 N-取代苯基-n'-取代杂环脲类化合物及其作为抗癌药物的应用
US9040712B2 (en) * 2013-01-23 2015-05-26 Novartis Ag Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions
CN104955332B (zh) 2013-01-30 2017-03-29 住友化学株式会社 防治节足害虫的方法
WO2014125426A1 (en) 2013-02-15 2014-08-21 Aurigene Discovery Technologies Limited Trisubstituted heterocyclic derivatives as ror gamma modulators
WO2015089327A1 (en) 2013-12-11 2015-06-18 Biogen Idec Ma Inc. Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology
US9758505B2 (en) 2014-02-12 2017-09-12 Iteos Therapeutics 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use
CN104876878B (zh) * 2014-02-27 2018-04-27 中国科学院广州生物医药与健康研究院 5-芳基酚-2烷基取代脲苯并咪唑类化合物及其应用
GB201416754D0 (en) 2014-09-23 2014-11-05 Mission Therapeutics Ltd Novel compounds
CN107001362A (zh) 2014-10-06 2017-08-01 默克专利有限公司 用作btk抑制剂的杂芳基化合物及其用途
US10426815B2 (en) * 2015-01-20 2019-10-01 The General Hospital Corporation Prevention and treatment of itch with an MRGPR antagonist
WO2016160938A1 (en) * 2015-04-02 2016-10-06 Abbvie Inc. N-(1,3-thiazol-2-yl)pyrimidine-5-carboxamides as trpv3 modulators
WO2017064068A1 (en) * 2015-10-14 2017-04-20 Almirall, S.A. New trpa1 antagonists
AR106679A1 (es) 2015-11-13 2018-02-07 Basf Se Oxadiazoles sustituidos para combatir hongos fitopatógenos
CN105924387A (zh) 2016-04-28 2016-09-07 西安交通大学 一种具有抗肿瘤活性的双芳基脲化合物及其制备方法和应用
PT3534899T (pt) * 2016-11-03 2022-07-07 Corvus Pharmaceuticals Inc Compostos e métodos de modulação da cinase de células t induzível por interleucina-2
WO2018114783A1 (en) 2016-12-23 2018-06-28 Bayer Pharma Aktiengesellschaft Tetrazole containing compounds
BR112019018230A2 (pt) 2017-03-02 2020-07-21 Assembly Biosciences, Inc. compostos de sulfamida cíclica e métodos de sua utilização
UY37957A (es) * 2017-11-02 2019-05-31 Abbvie Inc Moduladores de la vía de estrés integrada
CN107661328B (zh) * 2017-11-15 2019-08-23 西安交通大学 呋喃香豆素类化合物在制备抗过敏药物中的应用
EP3498694A1 (en) 2017-12-12 2019-06-19 Medibiofarma, S.L. New benzamide derivatives as ppar-gamma modulators
ES3043183T3 (en) * 2018-03-23 2025-11-25 Janssen Pharmaceutica Nv Compounds and uses thereof
CN108619183A (zh) * 2018-06-04 2018-10-09 西安交通大学 一种白芷中香豆素类化合物的简单提取方法及其应用
CN108451967B (zh) * 2018-06-04 2020-06-19 西安交通大学 克拉霉素在制备抗类过敏反应药物中的应用
EP4054570A1 (en) 2019-11-05 2022-09-14 Dermira, Inc Mrgprx2 antagonists and uses thereof
US20230029266A1 (en) 2019-11-05 2023-01-26 Dermira, Inc. MrgprX2 Antagonists for the Treatment of Inflammatory Disorders

Similar Documents

Publication Publication Date Title
JP2025148482A5 (cg-RX-API-DMAC7.html)
JP2022554392A5 (cg-RX-API-DMAC7.html)
JP2022554391A5 (cg-RX-API-DMAC7.html)
EP2582432B1 (en) Ureido-pyrazole derivatives for use in the treatment of rhinovirus infections
JP7651101B2 (ja) あざの処置のためのアリールアニリンおよびヘテロアリールアニリン化合物
ES2704922T3 (es) Compuesto de triazina y uso del mismo con fines médicos
CN111094255B (zh) 具有环状结构的化合物
RU2011121567A (ru) Изоиндолиновые соединения для применения при лечении рака
JP7576799B2 (ja) 皮膚癌の処置のためのアリールアニリンおよびヘテロアリールアニリン化合物
RU2006134021A (ru) Производные гетероарил-конденсированного пиразола
AU2004266719A1 (en) Methods of treating COPD and pulmonary hypertension
RU2015150946A (ru) Новые соединения для селективных ингибиторов гистондеацетилазы и фармацевтическая композиция, включающая такие соединения
JPWO2000047558A1 (ja) アミド化合物およびその医薬としての用途
JP2017502033A5 (cg-RX-API-DMAC7.html)
CN108892661A (zh) 治疗化合物和组合物
JP2025160175A5 (cg-RX-API-DMAC7.html)
CA2575541A1 (en) New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
JP2012531456A5 (cg-RX-API-DMAC7.html)
AU2018342423A1 (en) Griseofulvin compound and pharmaceutical use thereof
JP2009514909A (ja) 肺高血圧を処置するためのジアリールウレア
JP2010500334A5 (cg-RX-API-DMAC7.html)
US20180042922A1 (en) Compositions and methods of treating a neurodegenerative disease
ES2637539T3 (es) Polimorfos de ácido 4-{[4-({[4-(2,2,2-trifluoroetoxi)-1,2-benzoisoxazol-3-il]oxi}metil)piperidin-1-il]metil}-tetrahidro-2H-piran-4-carboxílico como agonistas del receptor de 5-hidroxitriptamina-4 (5-HT4) para el tratamiento de enfermedades gastrointestinales
WO2002045750A1 (en) Combination drugs
JP6219817B2 (ja) フェニルキサンテン誘導体